Sath Shukla, CEO & President: Spero Therapeutics SPRO Sell · Filed 24/08/29

Trade details

Type: Insider sale
Amount: $3,721.95
Shares · price: 2,757 sh · $1.35 a share
Held after: 1,140,809 sh
Stock: Spero Therapeutics SPRO
Person: Sath ShuklaCEO & President
Trade date: 24/08/27
Filed: 24/08/29
Days to filing: 2 days

Sold 0.2% of holdings

Share of holding sold: 0.2%

Spero Therapeutics trades, last 26 weeks

What else happened in Spero Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/28~24/09/26

Sath Shukla's recent trades

Sath ShuklaCEO & President
SellSpero Therapeutics
Sell
Spero Therapeutics
SPRO
$83K
106,408 sh
$83K
Filed 25/02/05
Traded 25/02/05
Sath ShuklaCEO & President
SellSpero Therapeutics
Sell
Spero Therapeutics
SPRO
$33.4K
42,786 sh
$33.4K
Filed 25/02/05
Traded 25/02/05
Sath ShuklaCEO & President
SellSpero Therapeutics
Sell
Spero Therapeutics
SPRO
$4,788
6,139 sh
$4,788
Filed 25/02/05
Traded 25/02/05
Sath ShuklaCEO and President
SellSpero Therapeutics
Sell
Spero Therapeutics
SPRO
$23.1K
17,641 sh
$23.1K
Filed 24/08/06
Traded 24/08/05
Sath ShuklaCEO and President
SellSpero Therapeutics
Sell
Spero Therapeutics
SPRO
$19.5K
14,800 sh
$19.5K
Filed 24/08/06
Traded 24/08/02